2023 Microbiome Market Trends Report 2023: Market is Successfully Commercializing Seres Therapeutics' SER-109 and Rebiotix's RBX-2660 for Recurrent Clostridium Difficile Infection

News provided by

Jan 09, 2024, 14:30 ET

DUBLIN, Jan. 9, 2024 /PRNewswire/ -- The "2023 Microbiome Market Trend" report has been added to ResearchAndMarkets.com's offering.

The microbiome therapeutics market is successfully commercializing Seres Therapeutics' SER-109 and Rebiotix's RBX-2660 for recurrent Clostridium difficile infection (Recurrent C. difficile).

While integrated omics-based projects are underway, researchers focus more on differences in gut microbiota between individuals that may be associated with disease expression. Still, they have yet to identify concrete biomarkers. While integrated omics analysis relies on correlation coefficients and algorithms, researchers are employing several omics approaches, and research is shifting from specific strains to multi-strain consortia.

This report covers the efforts of companies involved in the microbiome market. Also, it covers a wide range of topics, including market size, technology trends, applications in sequencing, health food, agriculture, livestock, skincare, industrial processes, regulations, and marketing. Trends in the global microbiome market are also summarized by country (and some areas), and the current market size, competitive landscape, and challenges are analyzed and forecasted for the future.

Countries Covered

United States
Canada
Germany
France
United Kingdom
China
Japan
India
Others

Key Topics Covered:

Chapter 1. Microbiome Market Trends

1.1 Microbiome Market Summary

1.2 Emerging Integrators

1.3 Major Probiotic Companies

1.4 Examples of Industrial Chains

1.5 Postbiotics

1.6 Regulation

1.7 Technology Platform Overview

1.8 Fecal Microbial Transplantation (FMT)

1.9 Encapsulation Technology

Chapter 2. Analysis by Microbiome application

2.1 Therapeutics

2.2 Diagnosis

2.3 Functional Food

2.4 Skin Care

2.5 Agriculture, Livestock and Fisheries

2.6 Industrial and other

Chapter 3. Trend Analysis by Company

3.1 Seres Therapeutics

3.2 Rebiotix

3.3 Evelo Biosciences

3.4 IFF(DuPont)

3.5 Chr. Hansen

3.6 Nestle

3.7 Probi

3.8 Yakult

3.9 Morinaga

Chapter 4. Market Size Forecast

Chapter 5. Trend Analysis by Country

Chapter 6. Conclusion

6.1. Competitive Environment Analysis

6.2 Digital Platforms and Marketing Strategies

6.3 Conclusion

Companies Mentioned

BGI
Chr. Hansen
DuPont
Enterome
Evelo Biosciences
Gallinee
Illumina
L'Oreal
Morinaga
Nestle
Probi
Rebiotix
Seres Therapeutics
Vedanta Biosciences
Yakult Honsha

For more information about this report visit https://www.researchandmarkets.com/r/tdigym

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg

SOURCE Research and Markets